PerkinElmer spends $5.3B on its fourth acquisition this year

Life sciences giant PerkinElmer Inc. (NYSE: PKI) is making yet another acquisition, this time the biggest in its history, buying San Diego, Calif.-based BioLegend for $5.25 billion in cash and stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.